INSYS Therapeutics Inc. (NASDAQ:INSY) and GTx Inc. (NASDAQ:GTXI), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation of the two firms.
Earnings and Valuation
Table 1 shows the gross revenue, earnings per share (EPS) and valuation for INSYS Therapeutics Inc. and GTx Inc.
Table 2 shows us INSYS Therapeutics Inc. and GTx Inc.’s return on assets, return on equity and net margins.
INSYS Therapeutics Inc. has a 2.56 beta, while its volatility is 156.00%, thus making it more volatile than Standard and Poor’s 500. GTx Inc. on the other hand, has 2.56 beta which makes it 156.00% more volatile compared to Standard and Poor’s 500.
The Current Ratio of INSYS Therapeutics Inc. is 0.7 while its Quick Ratio stands at 0.6. The Current